Clinical guidelines for the management of pouchitis

Inflammatory Bowel Diseases

Volumn 15, Issue 9, 2009, Pages 1424-1431

  Pardi, Darrell S ^a   D'Haens, Geert ^b   Shen, Bo ^c   Campbell, Simon ^d   Gionchetti, Paolo ^e  

^a MAYO CLINIC   (United States)

^b IMELDA HOSPITAL   (Belgium)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Ileal pouch anal anastomosis; Pouchitis; Ulcerative colitis

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CIPROFLOXACIN; CORTICOSTEROID; GANCICLOVIR; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PLACEBO; RIFAXIMIN; TINIDAZOLE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VANCOMYCIN;

ADENOMATOUS POLYP; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; CROHN DISEASE; CUFFITIS; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; DISEASE SEVERITY; ENDOSCOPY; ENTERITIS; ENTEROPATHY; FECES ANALYSIS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; INCIDENCE; INTESTINE BIOPSY; IRRITABLE POUCH SYNDROME; PATHOGENESIS; PELVIC ORGAN PROLAPSE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; UNSPECIFIED SIDE EFFECT; ARTICLE; ILEOSTOMY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; HUMANS; ILEOSTOMY; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS;

EID: 70449711098     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21039     Document Type: Review

References (69)

1. Marcello PW, Roberts PL, Schoetz DJ Jr, et al. Long-term results of the ileoanal pouch procedure. Arch Surg. 1993;128:500-503; discussion 503-504.
2. Hueting WE, Buskens E, van der Tweel I, et al. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg. 2005;22:69-79. (Pubitemid 40754695)
3. PennaC,Dozois R, TremaineW, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-239. (Pubitemid 26046819)
4. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497-500. (Pubitemid 26136371)
5. Stahlberg D, Gullberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012-1018.
6. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg. 2000;24:851-856.
7. Lovegrove RE, Tilney HS, Heriot AG, et al. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rect. 2006;49:1293-1306.
8. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800-803. (Pubitemid 28300513)
9. Shepherd NA, Hulten L, Tytgat GN, et al. Workshop: pouchitis. Int J Colorectal Dis. 1989;4:205-229.
10. Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001;121:261-267. (Pubitemid 32729373)
11. Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis. 1986;1:167-174.
12. Pardi DS, Sandborn WJ. Review article: management of pouchitis. Aliment Pharmacol Ther. 2006;23:1087-1096.
13. Shen B, Fazio VW, Remzi FH, et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:81-89. (Pubitemid 43129528)
14. Pardi DS, Shen B. Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis. Endoscopy. 2008;40:529-533. (Pubitemid 351911846)
15. Shen B, Lashner BA, Bennett AE, et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol. 2004;99:1527-1531. (Pubitemid 39180102)
16. Thompson-Fawcett MW, Mortensen NJ, Warren BF. "Cuffitis" and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis. Dis Colon Rectum. 1999;42:348-355.
17. Scarpa M, van Koperen PJ, Ubbink DT, et al. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg. 2007;94:534-545. (Pubitemid 46732235)
18. Shepherd NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol. 1987;40:601-607. (Pubitemid 17092838)
19. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc. 1994;69:409-415.
20. Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classi- fication and public health prospective. In: McLeod RS, Martin F, et al, eds. Trends in Inflammatory Bowel Disease 1996. Lancaster, UK: Kluwer Academic; 1997: 51-63.
21. Shen B. Diagnosis and management of patients with pouchitis. Drugs. 2003;65:453-461.
22. Yamamoto T, Umegae S, Kitagawa T, et al. The impact of the fecal stream and stasis on immunologic reactions in ileal pouch after restorative proctocolectomy for ulcerative colitis: a prospective, pilot study. Am J Gastroenterol. 2005;100:2248-2253. (Pubitemid 43919727)
23. Shen B, Goldblum JR, Hull TL, et al. Clostridium difficile-associated pouchitis. Dig Dis Sci. 2006;51:2361-2364.
24. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of ileoanal pouch as a refractory idiopathic chronic pouchitis. Report of two cases. Dis Colon Rectum. 1999;42:117-120.
25. Shen B, Fazio VW, Bennett AE, et al. Effect of withdrawal of nonsteroidal anti-inflammatory drug use in patients with the ileal pouch. Dig Dis Sci. 2007;52:3321-3328. (Pubitemid 350077174)
26. Shen B, Bennett AE, Fazio VW, et al. Collagenous pouchitis. Dig Liver Dis. 2006;38:704-709.
27. Heuschen UA, Hinz U, Allemeyer EH, et al. One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg. 2001;234:788-794. (Pubitemid 33117199)
28. Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis. Scand J Gastroenterol. 2000;35:1170-1173.
29. Fleshner P, Ippoliti A, Dubinsky M, et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouchanal anastomosis. Clin Gastroenterol Hepatol. 2007;5:952-958. (Pubitemid 47127022)
30. Achkar JP, Al-Haddad M, Lashner B, et al. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol. 2005;3:60-66. (Pubitemid 40092945)
31. Lohmuller JL, Pemberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg. 1990;211:622-6227.
32. Hata K, Watanabe T, Shinozaki M, et al. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol. 2003;38:1055-1058. (Pubitemid 37352469)
33. Merrett MN, Mortensen N, Kettlewell M, et al. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut. 1996;38:362-364. (Pubitemid 26074315)
34. Joelsson M, Benoni C, Oresland T. Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? Scand J Gastroenterol. 2006;41:929-933.
35. Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg. 1998;227:654-662.
36. Sengul N, Wexner SD, Hui SM, et al. Anatomic extent of colitis and disease severity are not predictors of pouchitis after restorative proctocolectomy for mucosal ulcerative colitis. Tech Coloproctol. 2006;10:29-34.
37. Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouchanal anastomosis. Am J Gastroenterol. 1995;90:740-747.
38. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut. 2001;49:671-677.
39. Aisenberg J, Legnani PE, Nilubol N, et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol. 2004;432-441.
40. Fleshner P, Ippoliti A, Dubinsky M, et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:561-568.
41. Carter MJ, Di Giovine FS, Cox A, et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology. 2001;121:805-811.
42. Meier CB, Hegazi RA, Aisenberg J, et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis. 2005;11:965-971.
43. Keighley MR. Review article: the management of pouchitis. Aliment Pharmacol Ther. 1996;10:449-457.
44. Baert RW. Pouchitis: a clarification. Gastroenterology. 1995;109:1022-1024.
45. Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology. 1993;104:981-988. (Pubitemid 23090748)
46. Sagar PM, Taylor BA, Godwin P, et al. Acute pouchitis and deficiencies of fuel. Dis Colon Rectum. 1995;38:488-493.
47. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci. 1994;39:1193-1196.
48. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301-305. (Pubitemid 33062095)
49. Isaacs KL, Sandler RS, Abreu M, et al. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007;13:1250-1255. (Pubitemid 47597772)
50. Nygaard K, Bergan T, Bjorneklett A, et al. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol. 1994;29:462-467.
51. Gionchetti P, Rizzello F, Morselli C, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum. 2007;50:2075-2082; discussion 2082-2084.
52. Miglioli M, Barbara L, Di Febo G, et al. Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis. N Engl J Med. 1989;320:257. (Pubitemid 19034161)
53. Shen B, Lashner BA, Bennett A, et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anatomosis. Am J Gastroenterol. 2004;99:1527-1531.
54. Tytgat GN, van Deventer SJ. Pouchitis. Int J Colorectal Dis. 1988;3:226-228.
55. Levin KE, Pemberton JH, Phillips SF, et al. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum. 1992;35:452-456.
56. Joelsson M, Andersson M, Bark T, et al. Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. Scand J Gastroenterol. 2001;36:1179-1184.
57. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis - a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther. 2002;16:27-34.
58. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther. 1999;13:713-718. (Pubitemid 29276839)
59. Mimura T, Rizzello F, Helwig U, et al. Four week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther. 2002;16:909-917. (Pubitemid 34461760)
60. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum. 2007;50:498-508. (Pubitemid 46701616)
61. Gionchetti P, Rizzello F, Poggioli G, et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther. 2007;25:1231-1236. (Pubitemid 46650294)
62. Chopra A, Pardi DS, Loftus EV Jr, et al. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice. Inflamm Bowel Dis. 2006;12:29-32. (Pubitemid 43032448)
63. Winter TA, Dalton HR, Merritt MN, et al. Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis.' Scand J Gastroenterol. 1993;28:701-704. (Pubitemid 23231991)
64. Hait EJ, Bousvaros A, Schuman M, et al. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007;42:31-34. (Pubitemid 46037709)
65. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759-764.
66. Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther. 2003;17:1263-1271. (Pubitemid 36693727)
67. Miner P Jr, Wedel M, Bane B, et al. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther. 2004;19:281-286.
68. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial. Gastroenterology. 2000;119:305-309. (Pubitemid 30621980)
69. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108-114. (Pubitemid 38083018)